Cargando…
A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach
BACKGROUND: The epidermal growth factor receptor (EGFR) overexpression is found in metastatic colorectal cancer (mCRC). Targeted molecular therapies such as monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKI) are becoming more precise, targeting specifically for cancer therapeutics. Ho...
Autores principales: | Lamtha, Thomanai, Krobthong, Sucheewin, Yingchutrakul, Yodying, Samutrtai, Pawitrabhorn, Gerner, Christopher, Tabtimmai, Lueacha, Choowongkomon, Kiattawee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109347/ https://www.ncbi.nlm.nih.gov/pubmed/35578244 http://dx.doi.org/10.1186/s12953-022-00190-6 |
Ejemplares similares
-
Exploring the Apoptotic-Induced Biochemical Mechanism of Traditional Thai Herb (Kerra™) Extract in HCT116 Cells Using a Label-Free Proteomics Approach
por: Siriwaseree, Jeeraprapa, et al.
Publicado: (2023) -
Utilizing Quantitative Proteomics to Identify Species-Specific
Protein Therapeutic Targets for the Treatment of Leishmaniasis
por: Krobthong, Sucheewin, et al.
Publicado: (2022) -
Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines
por: Lamtha, Thomanai, et al.
Publicado: (2022) -
Study of the Lipolysis Effect of Nanoliposome-Encapsulated Ganoderma lucidum Protein Hydrolysates on Adipocyte Cells Using Proteomics Approach
por: Krobthong, Sucheewin, et al.
Publicado: (2021) -
Evaluation of potential anti-metastatic and antioxidative abilities of natural peptides derived from Tecoma stans (L.) Juss. ex Kunth in A549 cells
por: Krobthong, Sucheewin, et al.
Publicado: (2022)